Literature DB >> 26214605

Non-alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization.

E Sabath1, A Báez-Ruiz1, R M Buijs1.   

Abstract

The circadian system, headed by the suprachiasmatic nucleus, synchronizes behaviour and metabolism according to the external light-dark cycle through neuroendocrine and autonomic signals. Metabolic diseases, such as steatosis, obesity and glucose intolerance, have been associated with conditions of circadian misalignment wherein the feeding schedule has been moved to the resting phase. Here we describe the physiological processes involved in liver lipid accumulation and show how they follow a circadian pattern importantly regulated by both the autonomic nervous system and the feeding-fasting cycle. We propose that an unbalanced activity of the sympathetic-parasympathetic branches between organs induced by circadian misalignment provides the conditions for the development and progression of non-alcoholic fatty liver disease.
© 2015 World Obesity.

Entities:  

Keywords:  Obesity; steatosis; suprachiasmatic; sympathetic

Mesh:

Substances:

Year:  2015        PMID: 26214605     DOI: 10.1111/obr.12308

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  8 in total

1.  Metabolic Dysfunction-Associated Fatty Liver Disease Increases the Risk of Gastroesophageal Reflux Symptoms.

Authors:  Yuan He; Zhi-Jun Duan; Cheng-Fang Wang; Yu-Shan Wei; Ming-Xu Cai
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-20       Impact factor: 3.168

2.  Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease.

Authors:  Mavidi Sunil Kumar; Akanksha Singh; Ashok Kumar Jaryal; Piyush Ranjan; K K Deepak; Sanjay Sharma; R Lakshmy; R M Pandey; Naval K Vikram
Journal:  Int J Hepatol       Date:  2016-12-08

Review 3.  Association between gastroesophageal reflux disease and nonalcoholic fatty liver disease: A meta-analysis.

Authors:  Karn Wijarnpreecha; Panadeekarn Panjawatanan; Charat Thongprayoon; Veeravich Jaruvongvanich; Patompong Ungprasert
Journal:  Saudi J Gastroenterol       Date:  2017 Nov-Dec       Impact factor: 2.485

4.  Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease.

Authors:  Inha Jung; Da Young Lee; Mi Yeon Lee; Hyemi Kwon; Eun-Jung Rhee; Cheol-Young Park; Ki-Won Oh; Won-Young Lee; Sung-Woo Park; Se Eun Park
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-08       Impact factor: 5.555

5.  Involvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A.

Authors:  Takashi Owaki; Kenya Kamimura; Masayoshi Ko; Itsuo Nagayama; Takuro Nagoya; Osamu Shibata; Chiyumi Oda; Shinichi Morita; Atsushi Kimura; Takeki Sato; Toru Setsu; Akira Sakamaki; Hiroteru Kamimura; Takeshi Yokoo; Shuji Terai
Journal:  Dis Model Mech       Date:  2022-07-26       Impact factor: 5.732

6.  Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging.

Authors:  Csaba Adori; Teresa Daraio; Raoul Kuiper; Swapnali Barde; Lubica Horvathova; Takashi Yoshitake; Robert Ihnatko; Ismael Valladolid-Acebes; Pauline Vercruysse; Ashley M Wellendorf; Roberto Gramignoli; Bela Bozoky; Jan Kehr; Elvar Theodorsson; Jose A Cancelas; Boris Mravec; Carl Jorns; Ewa Ellis; Jan Mulder; Mathias Uhlén; Christina Bark; Tomas Hökfelt
Journal:  Sci Adv       Date:  2021-07-21       Impact factor: 14.136

Review 7.  Evolving roles of circadian rhythms in liver homeostasis and pathology.

Authors:  Dexi Zhou; Yaqin Wang; Lu Chen; Leijuan Jia; Jie Yuan; Mei Sun; Wen Zhang; Peipei Wang; Jian Zuo; Zhenyu Xu; Jiajie Luan
Journal:  Oncotarget       Date:  2016-02-23

8.  Peripheral circadian rhythms in the liver and white adipose tissue of mice are attenuated by constant light and restored by time-restricted feeding.

Authors:  Daisuke Yamamuro; Manabu Takahashi; Shuichi Nagashima; Tetsuji Wakabayashi; Hisataka Yamazaki; Akihito Takei; Shoko Takei; Kent Sakai; Ken Ebihara; Yusaku Iwasaki; Toshihiko Yada; Shun Ishibashi
Journal:  PLoS One       Date:  2020-06-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.